Live Breaking News & Updates on Foresight Acquisition Corp

Stay updated with breaking news from Foresight acquisition corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investment Analysts' Upgrades for May 10th (ADTN, AEL, ARLP, BAX, CLNE, CMA, CP, DMPZF, EADSY, EOG)

Investment Analysts’ upgrades for Tuesday, May 10th: ADTRAN (NASDAQ:ADTN) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $20.00 price target on the stock. According to Zacks, “ADTRAN reported relatively healthy first-quarter 2022 results, wherein both the bottom and the top lines beat the […] ....

United States , Fort Lee , New Jersey , Hong Kong , United Kingdom , New York , Miami Beach , Cayman Islands , Societe Generale , Kulicke Soffa , Raymond James , Las Vegas Sands , Las Vegas , Soffa Industries , Holdings Inc , National Retail Properties , Oppenheimer Holdings Inc , Insight Enterprises Inc , Runway Growth Finance Corp , Research Triangle Park , Barrington Research , Servisfirst Bancshares Inc , Sandbridge Acquisition Corporation , Domino Pizza Group , Merchants Bancorp , Devices Inc ,

Zacks Investment Research Lowers P3 Health Partners (NASDAQ:PIII) to Sell

P3 Health Partners (NASDAQ:PIII – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is […] ....

United States , William Blair , Penserra Capital Management , Health Partners , Zacks Investment Research , Foresight Acquisition Corp , Health Partners Get Rating , Gm Advisory Group Inc , Health Partners Inc , Citadel Advisors , Ingalls Snyder , Get Rating , Capital Management , Partners Inc , P3 Health Partners , Nasdaq Piii ,

P3 Health Partners (NASDAQ:PIII) Stock Rating Lowered by Zacks Investment Research

P3 Health Partners (NASDAQ:PIII – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., […] ....

United States , Michael Balkin , William Blair , Penserra Capital Management , Geode Capital Management , Health Partners , Zacks Investment Research , Foresight Acquisition Corp , Health Partners Company Profile Get Rating , Blair William Co , Citadel Advisors , Health Partners Inc , Get Rating , Capital Management , Partners Company Profile , Partners Inc , P3 Health Partners , Nasdaq Piii ,